MillerKnoll (MLKN) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
9 Jul, 2026Executive summary
Q2 FY2025 net sales rose 2.2% year-over-year to $970.4 million, with organic growth of 2.4%; orders declined 2.3% as reported and 1.9% organically, driven by timing shifts in retail promotions.
Adjusted EPS for Q2 FY2025 was $0.55, down from $0.59 last year; reported EPS was $0.49, up from $0.45.
Americas Contract segment led growth with net sales up 5.9% (6.2% organic) and orders up 4.4%; Global Retail sales declined 5.3% due to promotional timing.
Returned $93.1 million to shareholders via dividends and share repurchases in the first half of FY2025.
Cash flow from operations in Q2 was $55.3 million; liquidity at quarter-end was $470.4 million.
Financial highlights
Q2 consolidated net sales: $970.4 million, up 2.2% year-over-year (2.4% organic); Q2 consolidated orders: $921.9 million, down 2.3% reported and 1.9% organic.
Gross margin: 38.8%, slightly down from 39.2% last year due to product and channel mix.
Adjusted operating margin: 7.1%, down from 7.9% year-over-year; operating margin: 6.4% (flat year-over-year).
Net earnings attributable to MillerKnoll: $34.1 million, up 1.8% year-over-year.
Net debt-to-EBITDA ratio stood at 2.94x at quarter-end.
Outlook and guidance
Q3 FY2025 net sales expected between $903 million and $943 million; adjusted EPS guidance of $0.41–$0.47.
Full-year FY2025 adjusted EPS guidance narrowed to $2.11–$2.17, reflecting slower macro improvements and lower orders in H1.
Guidance reflects $12 million in Global Retail net sales and $27 million in orders shifting from Q2 to Q3 due to holiday promotional timing.
Full-year sales and EPS still expected to grow over FY2024.
Expectation of improved demand in H2 FY2025, supported by internal and external leading indicators.
Latest events from MillerKnoll
- Gross margin and adjusted EPS rose in Q4, with improving order trends and a positive FY2025 outlook.MLKN
Q4 20249 Jul 2026 - Q4 net sales up 4.4% to $1.004B; FY27 guidance: $3.93B–$4.13B sales, $1.85–$2.15 EPS.MLKN
Q4 202624 Jun 2026 - Q3 FY26 delivered higher sales, margin gains, and strong liquidity amid global uncertainties.MLKN
Q3 202630 Mar 2026 - Order and backlog growth offset lower sales; FY2025 adjusted EPS guidance reaffirmed.MLKN
Q1 202520 Jan 2026 - Orders rose 5.5% and gross margin hit 39.0%, offsetting a 1.6% sales decline.MLKN
Q2 20265 Jan 2026 - $130M impairment drove Q3 loss, but retail orders and guidance remain strong.MLKN
Q3 202526 Dec 2025 - Profitability improved, global reach expanded, and sustainability advanced; all proposals recommended for approval.MLKN
Proxy Filing1 Dec 2025 - Shareholders to vote on directors, executive pay, auditor, and new incentive plan amid growth focus.MLKN
Proxy Filing1 Dec 2025 - Key votes: director elections, executive pay, auditor ratification, and incentive plan approval.MLKN
Proxy Filing1 Dec 2025